GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy: A Positron Emission Tomography and Transcranial Magnetic Stimulation Study
- PMID: 38151012
- PMCID: PMC10871686
- DOI: 10.1159/000535512
GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy: A Positron Emission Tomography and Transcranial Magnetic Stimulation Study
Abstract
Introduction: Gamma-aminobutyric acid (GABA) deficiency is suggested in depressive disorders, along with alterations in cortical excitability. However, whether these excitability changes are related to GABAA receptor availability is largely unknown. Our aim was to assess the correlation between these measures in depressed patients and healthy controls.
Methods: Twenty-eight patients with a major depressive episode, measured before and after participating in a clinical trial with repetitive transcranial magnetic stimulation (TMS), and 15 controls underwent [11C]flumazenil positron emission tomography to assess GABAA receptor availability and paired pulse TMS (ppTMS) to evaluate cortical excitability. Both whole-brain voxel-wise GABAA receptor availability and mean values from left hand motor cortex and left paracentral lobule were correlated to the ppTMS outcomes: short-interval intracortical inhibition reflecting GABAA receptor activity, long-interval intracortical inhibition representing GABAB receptor activity, intracortical facilitation reflecting glutamate N-methyl-D-aspartate-receptor activity, as well as the resting motor threshold (rMT), considered a global measure of corticospinal excitability.
Results: No significant differences in baseline GABAA receptor availability or cortical excitability were found between patients and controls. Additionally, no correlations were observed between baseline measurements of GABAA receptor availability and TMS outcomes. Changes in GABAA receptor availability in the hand motor cortex, between pre- and post-assessments, were inversely related to pre-post changes in hand rMT.
Conclusion: We found that a change in GABAA receptor availability was inversely related to a change in rMT, suggesting a link between GABA deficiency and increased rMT previously observed in depressive episodes. The results highlight the complex mechanisms governing cortical excitability measures and offer new insight into their properties during the depressive state.
Keywords: Intracortical facilitation; Long-interval intracortical inhibition; N-methyl-D-asparate; Paired pulse transcranial magnetic stimulation; Short-interval intracortical inhibition.
© 2023 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures


Similar articles
-
An Exploratory Study of Spectroscopic Glutamatergic Correlates of Cortical Excitability in Depressed Adolescents.Front Neural Circuits. 2016 Nov 29;10:98. doi: 10.3389/fncir.2016.00098. eCollection 2016. Front Neural Circuits. 2016. PMID: 27965544 Free PMC article.
-
Short-interval and long-interval intracortical inhibition of TMS-evoked EEG potentials.Brain Stimul. 2018 Jul-Aug;11(4):818-827. doi: 10.1016/j.brs.2018.03.008. Epub 2018 Mar 15. Brain Stimul. 2018. PMID: 29572124 Clinical Trial.
-
GABA levels and measures of intracortical and interhemispheric excitability in healthy young and older adults: an MRS-TMS study.Neurobiol Aging. 2018 May;65:168-177. doi: 10.1016/j.neurobiolaging.2018.01.023. Epub 2018 Feb 6. Neurobiol Aging. 2018. PMID: 29494863
-
Pharmaco-transcranial magnetic stimulation studies of motor excitability.Handb Clin Neurol. 2013;116:387-97. doi: 10.1016/B978-0-444-53497-2.00032-2. Handb Clin Neurol. 2013. PMID: 24112911 Review.
-
Phosphene and motor transcranial magnetic stimulation thresholds are correlated: A meta-analytic investigation.Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jul 13;133:111020. doi: 10.1016/j.pnpbp.2024.111020. Epub 2024 Apr 29. Prog Neuropsychopharmacol Biol Psychiatry. 2024. PMID: 38692474 Review.
Cited by
-
GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases.MedComm (2020). 2025 Apr 16;6(5):e70163. doi: 10.1002/mco2.70163. eCollection 2025 May. MedComm (2020). 2025. PMID: 40242161 Free PMC article. Review.
References
-
- Sieghart W, Savić MM. International union of basic and clinical pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans. Pharmacol Rev. 2018;70(4):836–78. - PubMed
-
- Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psychiatry. 2003;8(8):721–37. - PubMed